keratan-sulfate and Burkitt-Lymphoma

keratan-sulfate has been researched along with Burkitt-Lymphoma* in 1 studies

Other Studies

1 other study(ies) available for keratan-sulfate and Burkitt-Lymphoma

ArticleYear
Sulfation of keratan sulfate proteoglycan reduces radiation-induced apoptosis in human Burkitt's lymphoma cell lines.
    FEBS letters, 2013, Jan-16, Volume: 587, Issue:2

    This study focuses on clarifying the contribution of sulfation to radiation-induced apoptosis in human Burkitt's lymphoma cell lines, using 3'-phosphoadenosine 5'-phosphosulfate transporters (PAPSTs). Overexpression of PAPST1 or PAPST2 reduced radiation-induced apoptosis in Namalwa cells, whereas the repression of PAPST1 expression enhanced apoptosis. Inhibition of PAPST slightly decreased keratan sulfate (KS) expression, so that depletion of KS significantly increased radiation-induced apoptosis. In addition, the repression of all three N-acetylglucosamine-6-O-sulfotransferases (CHST2, CHST6, and CHST7) increased apoptosis. In contrast, PAPST1 expression promoted the phosphorylation of p38 MAPK and Akt in irradiated Namalwa cells. These findings suggest that 6-O-sulfation of GlcNAc residues in KS reduces radiation-induced apoptosis of human Burkitt's lymphoma cells.

    Topics: Anion Transport Proteins; Apoptosis; Base Sequence; Burkitt Lymphoma; Cell Line, Tumor; Humans; Keratan Sulfate; MAP Kinase Signaling System; Membrane Transport Proteins; Proteoglycans; Radiation Tolerance; RNA, Small Interfering; Sulfate Transporters; Sulfuric Acid Esters

2013